| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 96.60B | 96.43B | 94.56B | 104.21B | 88.08B | 97.27B |
| Gross Profit | 29.53B | 28.75B | 24.51B | 30.17B | 25.91B | 20.61B |
| EBITDA | 17.93B | 17.78B | 14.25B | 19.04B | 16.32B | 12.42B |
| Net Income | 10.59B | 10.33B | 7.65B | 10.57B | 9.44B | 6.05B |
Balance Sheet | ||||||
| Total Assets | 153.24B | 153.94B | 150.54B | 138.03B | 129.16B | 119.37B |
| Cash, Cash Equivalents and Short-Term Investments | 40.39B | 43.31B | 38.43B | 36.84B | 37.02B | 31.93B |
| Total Debt | 8.23B | 8.40B | 8.51B | 8.58B | 16.89B | 16.97B |
| Total Liabilities | 35.96B | 38.33B | 40.77B | 38.48B | 45.26B | 42.14B |
| Stockholders Equity | 117.27B | 115.59B | 109.76B | 99.53B | 83.90B | 77.23B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 10.31B | 3.48B | 4.58B | 7.69B | 7.58B |
| Operating Cash Flow | 0.00 | 17.05B | 8.60B | 9.35B | 13.38B | 9.35B |
| Investing Cash Flow | 0.00 | -8.13B | -4.26B | -5.38B | -6.96B | -1.85B |
| Financing Cash Flow | 0.00 | -4.22B | -3.20B | -4.60B | -1.65B | -4.46B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥358.31B | 5.46 | 9.34% | 4.27% | -0.48% | -35.29% | |
79 Outperform | ¥352.81B | 14.16 | 9.59% | 3.91% | 0.87% | 16.71% | |
74 Outperform | ¥303.74B | 9.05 | 5.47% | 3.41% | 2.60% | 9.50% | |
65 Neutral | ¥273.99B | 11.03 | 9.45% | 2.65% | -0.04% | 3.15% | |
65 Neutral | ¥245.79B | 6.13 | 1.47% | 4.29% | -7.45% | -71.68% | |
63 Neutral | ¥238.90B | 17.36 | ― | 1.00% | -3.06% | 45.21% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |